Docstoc

Aarkstore Enterprise-TopoTarget A/S – Product Pipeline Review – 2012

Document Sample
Aarkstore Enterprise-TopoTarget A/S – Product Pipeline Review – 2012 Powered By Docstoc
					Aarkstore.com announces, The Latest market research report is available in
its vast collection:

TopoTarget A/S – Product Pipeline Review – 2012



More about this report


You can also request for sample page of above mention reports on
sample@aarkstore.com



Summary

Global Markets Direct’s pharmaceuticals report, “TopoTarget A/S - Product Pipeline
Review - 2012” provides data on the TopoTarget A/S’s research and development
focus. The report includes information on current developmental pipeline, complete
with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s
proprietary databases, TopoTarget A/S’s corporate website, SEC filings, investor
presentations and featured press releases, both from TopoTarget A/S and industry-
specific third party sources, put together by Global Markets Direct’s team.

Scope

- TopoTarget A/S - Brief TopoTarget A/S overview including business description,
key information and facts, and its locations and subsidiaries.
- Review of current pipeline of TopoTarget A/S human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development,
including the combination treatment modalities, across the globe.
Table of contents:

List of Tables 4
List of Figures 5
TopoTarget A/S Snapshot 6
TopoTarget A/S Overview 6
Key Information 6
Key Facts 6
TopoTarget A/S – Research and Development Overview 7
Key Therapeutic Areas 7
TopoTarget A/S – Pipeline Review 10
Pipeline Products by Stage of Development 10
Pipeline Products – Monotherapy 11
Pipeline Products – Combination Treatment Modalities 12
TopoTarget A/S – Pipeline Products Glance 13
TopoTarget A/S Clinical Stage Pipeline Products 13
Phase II Products/Combination Treatment Modalities 13
Phase I Products/Combination Treatment Modalities 14
TopoTarget A/S – Early Stage Pipeline Products 15
Pre-Clinical Products/Combination Treatment Modalities 15
TopoTarget A/S – Drug Profiles 16
APO010 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
Belinostat 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Belinostat + Azacitidine 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
Belinostat + Bortezomib 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
Belinostat + Carboplatin + Paclitaxel 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Belinostat + Cisplatin + Doxorubicin + Cyclophosphamide 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
Belinostat + Doxorubicin 27
Product Description 27
Mechanism of Action 27
R&D Progress 27



List of Figures

List of Tables are also include.



For more related Reports Plz follow The link:

Product Pipeline Review – 2012
http://www.aarkstore.com/search/viewresults.asp?search=Product Pipeline
Review – 2012&PubId=&pagenum=1




MacroGenics, Inc. – Product Pipeline Review – 2012

TopoTarget A/S – Product Pipeline Review – 2012

YM BioSciences Inc. – Product Pipeline Review – 2012

ZIOPHARM Oncology, Inc. – Product Pipeline Review – 2012
Zydus Cadila Healthcare Limited – Product Pipeline Review – 2012

Acucela Inc. – Product Pipeline Review – 2012

Aldagen, Inc. – Product Pipeline Review – 2012

Bellicum Pharmaceuticals, Inc. – Product Pipeline Review – 2012

DiaKine Therapeutics, Inc. – Product Pipeline Review – 2012

Dong-A Pharmaceutical Co., Ltd. – Product Pipeline Review – 2012




Search More Reports Related to This Category :


Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1




For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

				
DOCUMENT INFO
Shared By:
Categories:
Stats:
views:3
posted:9/27/2012
language:
pages:4